Submission of voting results along with scrutinizers report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) held an Extra Ordinary General Meeting on May 9, 2025 via video conferencing. Two resolutions were put to vote and both passed with overwhelming majority. Resolution 1 (Special Resolution) confirmed the appointment of Mr. Lakshman Samala (DIN: 10783725) as Independent Director, receiving 7,017,463 votes in favor (99.9994%) and just 5 votes against (0.0006%). Resolution 2 (Ordinary Resolution) confirmed the appointment of Mr. Jivamohan Divakar Valuri (DIN: 09218013) as Non-Executive Non-Independent Director, with the same voting pattern of 7,017,463 in favor (99.9994%) and 5 against (0.0006%). The total shareholder base on the record date (May 2, 2025) was 2,475 shareholders, with 1 promoter and 25 public shareholders attending through VC. The scrutinizer, Ankur Khedar of Khedar Ankur & Associates, validated the e-voting process conducted via CDSL.
Two new directors have been formally appointed to the board — an Independent Director and a Non-Executive Non-Independent Director. The near-unanimous voting (99.9994% in favor) signals strong shareholder support and no governance friction. For shareholders, this means a board refresh with a new independent oversight voice, though the near-zero dissent suggests the resolutions were largely procedural.